Tandem Diabetes Care Announces Partnership With JDRF To Develop A Novel pump

Status
Not open for further replies.
Northerner

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Tandem Diabetes Care, Inc. ("Tandem") announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a first-of-its-kind, dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system using therapies in conjunction with insulin.
"An ambulatory device that can simultaneously deliver insulin along with other drug therapies that are used for optimal diabetes management is not currently commercially available," said Kim D. Blickenstaff , president and CEO of Tandem. "The combination of JDRF's expertise and advocacy along with Tandem's unique technology and passion for meeting unmet needs in the diabetes community offers the opportunity for an exciting step toward the ultimate artificial pancreas solution."
JDRF will support Tandem in performance-based milestone funding over the next two years to complete the development, testing, and manufacturing of a novel infusion pump that can simultaneously deliver two injectable hormonal drug therapies.

http://www.prnewswire.com/news-rele...vel-dual-chamber-infusion-pump-186011072.html
 
If as they say the extra hormones need to be delivered, why can't they just be added to the insulin that is manufactured? Not everyone has or wants a pump.
 
Pumper_Sue said:
If as they say the extra hormones need to be delivered, why can't they just be added to the insulin that is manufactured? Not everyone has or wants a pump.
Click to expand...

Perhaps they need to be delivered separately, and in different quantities? So, kept apart but delivered through the same cannula?
 
I wondered what possible/probable other hormones they were on about?
 
Status
Not open for further replies.
Back
Top